Bone meta (-)Bone meta (+) n=101n=57p-value Age (min-max)73.0 (51-88)71.0 (55-86)0.027 BMI (min-max)...

8
Bone meta (-) Bone meta (+) n=101 n=57 p- value Age (min-max) 73.0 (51-88) 71.0 (55-86) 0.027 BMI (min-max) PrePSA (min-max) 24.0 (16.0-32) 20.0 (2.0- 982.0) 23.0 (17-28) 139.0 (7.8- 6262.0) 0.037 0.001 Gleason score 0.006 ≤6 24 (23.8) 3 (5.3) 7 29 (28.7) 15 (26.3) ≥8 48 (47.5) 39 (68.4) Posttreatment PSA nadir 0.04 (0.01- 30.4) 0.2 (0.01- 79.8) 0.04 A. C. B. T1 and T2 T3 and T4 Lee et al. Supp Fig 1

Transcript of Bone meta (-)Bone meta (+) n=101n=57p-value Age (min-max)73.0 (51-88)71.0 (55-86)0.027 BMI (min-max)...

Page 1: Bone meta (-)Bone meta (+) n=101n=57p-value Age (min-max)73.0 (51-88)71.0 (55-86)0.027 BMI (min-max) PrePSA (min-max) 24.0 (16.0-32) 20.0 (2.0-982.0) 23.0.

Bone meta (-) Bone meta (+)

n=101 n=57 p-value

Age (min-max) 73.0 (51-88) 71.0 (55-86) 0.027BMI (min-max)PrePSA (min-

max)

24.0 (16.0-32)20.0 (2.0-

982.0)

23.0 (17-28)139.0 (7.8-

6262.0)

0.0370.001

Gleason score 0.006≤6 24 (23.8) 3 (5.3)7 29 (28.7) 15 (26.3)

≥8 48 (47.5) 39 (68.4)Posttreatment

PSA nadir0.04 (0.01-

30.4)0.2 (0.01-79.8) 0.04

A.

C.

B.

T1 and T2 T3 and T4

Lee et al. Supp Fig 1

Page 2: Bone meta (-)Bone meta (+) n=101n=57p-value Age (min-max)73.0 (51-88)71.0 (55-86)0.027 BMI (min-max) PrePSA (min-max) 24.0 (16.0-32) 20.0 (2.0-982.0) 23.0.

LNCaP 22RV1

Lee et al. Supp Fig 2

Page 3: Bone meta (-)Bone meta (+) n=101n=57p-value Age (min-max)73.0 (51-88)71.0 (55-86)0.027 BMI (min-max) PrePSA (min-max) 24.0 (16.0-32) 20.0 (2.0-982.0) 23.0.

Lee et al. Supp Fig 3

A.*

0

50

100

150

200

250

Con BMP-6 1ng/ml BMP-610ng/ml

Cel

l co

un

ts (

% o

f co

n)

1d 2d 3d 4d

** *

**

*

B.

0

50

100

150

200

22RV1+WPMY-1 22RV1+HS-5

Ce

ll c

ou

nts

(%

of

co

n)

IgG BMP-6 Ab

C.

*

Page 4: Bone meta (-)Bone meta (+) n=101n=57p-value Age (min-max)73.0 (51-88)71.0 (55-86)0.027 BMI (min-max) PrePSA (min-max) 24.0 (16.0-32) 20.0 (2.0-982.0) 23.0.

BMPRII

ActRIIa

ActRIIb

β-actin

Con

siRN

A

BM

PR

II siR

NA

ActR

IIa siR

NA

ActR

IIb siR

NA

BMPRIa

BMPRIb

ActRIa

β-actin

Con

siRN

A

BM

PR

Ia siR

NA

BM

PR

Ib siR

NA

ActR

Ia siR

NA

Smad1

Smad5

Smad8

β-actin

Con

siRN

A

Sm

ad1 siR

NA

Sm

ad5 siR

NA

Sm

ad8 siR

NA

Lee et al. Supp Fig 4

Page 5: Bone meta (-)Bone meta (+) n=101n=57p-value Age (min-max)73.0 (51-88)71.0 (55-86)0.027 BMI (min-max) PrePSA (min-max) 24.0 (16.0-32) 20.0 (2.0-982.0) 23.0.

Wnt5a

β-actin

LNCaP 22RV1

WPM

Y-1

HS-5

WPM

Y-1

H-5Stromal

Cell line- - --

Lee et al. Supp Fig 5

Page 6: Bone meta (-)Bone meta (+) n=101n=57p-value Age (min-max)73.0 (51-88)71.0 (55-86)0.027 BMI (min-max) PrePSA (min-max) 24.0 (16.0-32) 20.0 (2.0-982.0) 23.0.

Lee et al. Supp Fig 6

22RV1

SP600125:10uM, Calphostin C:100nM

Wnt5a - + + +

Inhibitor - -

SP60

012

5

Calp

hosti

n C

JNKi PKCi

0

1

2

3

4

5

6

7

8

9

Fo

ld in

cre

as

e

Wnt5a - + + +

Inhibitor - -

SP60

012

5

Calp

hosti

n C

JNKi PKCi

BMP-6

-actin

Page 7: Bone meta (-)Bone meta (+) n=101n=57p-value Age (min-max)73.0 (51-88)71.0 (55-86)0.027 BMI (min-max) PrePSA (min-max) 24.0 (16.0-32) 20.0 (2.0-982.0) 23.0.

Lux

Lux

Lux

Lux

Lux

Lux

ATG

TATA CATNF-B

0 1 2 3 4

pGL3

0.3kb

0.6kb

0.9kb

1.2kb

1.5kb

BMP-6 Lux activity (Fold)

Lee et al. Supp Fig 7

Page 8: Bone meta (-)Bone meta (+) n=101n=57p-value Age (min-max)73.0 (51-88)71.0 (55-86)0.027 BMI (min-max) PrePSA (min-max) 24.0 (16.0-32) 20.0 (2.0-982.0) 23.0.

PCKNF-B receptor

Lee et al. Supp Fig 8